Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 404-412

  Ishikado, Atsushi ^a,b   Nishio, Yoshihiko ^a   Yamane, Kazuko ^b   Mukose, Atsushi ^a   Morino, Katsutaro ^a   Murakami, Yoko ^b   Sekine, Osamu ^a   Makino, Taketoshi ^b   Maegawa, Hiroshi ^a   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Sunstar Incorporated Company   (Japan)

Author keywords

HUVEC; MCP 1; Saturated fatty acids; Soy phosphatidylcholine; TLR4; Vascular smooth muscle cell

Indexed keywords

CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PALMITIC ACID; PHOSPHATIDYLCHOLINE; PROTEIN KINASE C; SATURATED FATTY ACID; SMALL INTERFERING RNA; STEARIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIMULUS LYSATE TEST; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HORSESHOE CRABS; HUMANS; INFLAMMATION; MALE; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SOYBEANS; TOLL-LIKE RECEPTOR 4;

EID: 67650869916     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.010     Document Type: Article

References (34)

1. Wilding J.P. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 24 (2007) 934-945
2. Bergman R.N., Kim S.P., Hsu I.R., et al. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120 (2007) S3-8
3. Lee J.Y., Sohn K.H., Rhee S.H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276 (2001) 16683-16689
4. Hwang D. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J 15 (2001) 2556-2564
5. Lee J.Y., Ye J., Gao Z., et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 278 (2003) 37041-37051
6. Shi H., Kokoeva M.V., Inouye K., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116 (2006) 3015-3025
7. Suganami T., Tanimoto-Koyama K., Nishida J., et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27 (2007) 84-91
8. Kim F., Pham M., Luttrell I., et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100 (2007) 1589-1596
9. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
10. Pasterkamp G., Van Keulen J.K., and De Kleijn D.P. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34 (2004) 328-334
11. Björkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr Opin Lipidol 17 (2006) 527-533
12. Bochkov V.N., Kadl A., Huber J., et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419 (2002) 77-81
13. Walton K.A., Cole A.L., Yeh M., et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 23 (2003) 1197-1203
14. Mullarkey M., Rose J.R., Bristol J., et al. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 304 (2003) 1093-1102
15. Kawamoto T., Ii M., Kitazaki T., Iizawa Y., and Kimura H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 584 (2008) 40-48
16. Cao Q., Mak K.M., and Lieber C.S. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. Biochem Biophys Res Commun 294 (2002) 849-853
17. Carluccio M.A., Massaro M., Bonfrate C., et al. Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the Mediterranean diet. Arterioscler Thromb Vasc Biol 19 (1999) 220-228
18. Sekine O., Nishio Y., Egawa K., et al. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 277 (2002) 36631-36639
19. Wang Y., Rangan G.K., Goodwin B., Tay Y.C., and Harris D.C. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int 57 (2000) 2011-2022
20. Weigert C., Brodbeck K., Staiger H., et al. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 279 (2004) 23942-23952
21. Jové M., Planavila A., Laguna J.C., and Vázquez-Carrera M. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 146 (2005) 3087-3095
22. Jové M., Planavila A., Sánchez R.M., et al. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 147 (2006) 552-561
23. Håversen L., Danielsson K.N., Fogelstrand L., and Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202 (2009) 382-393
24. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
25. Chapman Jr. G.W. A conversion factor to determine phospholipid content in soybean and sunflower crude oils. J Am Oil Chem Soc 57 (1980) 299-302
26. Weber E.J. Compositions of commercial corn and soybean lecithins. J Am Oil Chem Soc 58 (1981) 898-901
27. Poggi M., Bastelica D., Gual P., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50 (2007) 1267-1276
28. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 (2007) 1986-1998
29. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
30. Björkbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10 (2004) 416-421
31. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 101 (2004) 10679-10684
32. Li H., He Y., Zhang J., Sun S., and Sun B. Lipopolysaccharide regulates toll-like receptor 4 expression in human aortic smooth muscle cells. Cell Biol Int 31 (2007) 831-835
33. Heo S.K., Yun H.J., Noh E.K., Park W.H., and Park S.D. LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production. Immunol Lett 120 (2008) 57-64
34. Dauphinee S.M., and Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest 86 (2006) 9-22